UPDATE 1-Valeant's former CEO to receive $9 mln severance payment, other fees

NEW YORK, May 31 (Reuters) - Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International , will receive a $9 million severance payment and agreed to a consulting agreement worth hundreds of thousands of dollars, according to a document filed with regulators.